ABSTRACT Epidemiologic observations that have been made in the context of the current pandemic influenza virus include a stable virulence phenotype and a lack of propensity to reassort with seasonal strains. In an attempt to determine whether either of these observations could change in the future, we coinfected differentiated human airway cells with seasonal oseltamivirresistant A/New Jersey/15/07 and pandemic A/Tennessee/1-560/09 (H1N1) viruses in three ratios (10:90, 50:50, and 90:10) and examined the resulting progeny viruses after 10 sequential passages. When the pandemic virus was initially present at multiplicities of infection equal to or greater than those for the seasonal virus, only pandemic virus genotypes were detected. These adapted pandemic strains did, however, contain two nonsynonymous mutations (hemagglutinin K154Q and polymerase acidic protein L295P) that conferred a more virulent phenotype, both in cell cultures and in ferrets, than their parental strains. The polymerase acidic protein mutation increased polymerase activity at 37°C, and the hemagglutinin change affected binding of the virus to ␣2,6-sialyl receptors. When the seasonal A/H1N1 virus was initially present in excess, the dominant progeny virus was a reassortant containing the hemagglutinin gene from the seasonal strain and the remaining genes from the pandemic virus. Our study demonstrates that the emergence of an A/H1N1 pandemic strain of higher virulence is possible and that, despite their lack of detection thus far in humans, viable seasonal/pandemic virus reassortants can be generated.
RESULTS
Coinfection of seasonal and pandemic A/H1N1 influenza virus strains in differentiated human cells. We used differentiated normal human bronchial epithelial (NHBE) cells as a model to mimic A/H1N1 virus evolution in humans. NHBE cells were coinfected with oseltamivir-resistant seasonal A/New Jersey/15/07 (NJ/15) and pandemic A/Tennessee/1-560/09 (TN/560) (H1N1) viruses in different ratios (10:90, 50 :50, and 90:10). The virus mixtures were serially passaged 10 times to provide an opportunity for selection of efficiently adapted genotypes. After three sequential passages, viruses isolated from all coinfection groups were plaque purified in Madin-Darby canine kidney (MDCK) cells, and 25 clones per group were genotyped to establish the origin of each of the eight genes that constitute the influenza virus ( Fig. 1) (8, 9) . The method was not quantitative and was used as a rough estimate of virus genes present. Among all the samples analyzed, TN/560 dominated over NJ/15, although dual genotypes (plaques containing the same genes of both parental viruses) were still present for all genes and in all three groups. Notably, viruses carrying the NJ/15 hemagglutinin (HA) gene were isolated at higher frequencies (39 to 50%) from NHBE cultures that were initially coinfected with a proportion of seasonal A/H1N1 equal to or higher than that of the pandemic virus ( Fig. 1B and C) .
We assayed whether pandemic/seasonal reassortants could be favored by analyzing viral genomes (n ϭ 30) after 10 passages in NHBE cells (Table 1). A unique reassortant carrying NJ/15 HA in a TN/560 backbone was systemically selected (92%) in the group with an initial predominance of NJ/ 15. In the two other coinfection groups, all recovered viruses possessed all eight genes from the pandemic TN/560 virus ( Table 1 ). The proportions of HA and NA RNAs of each virus after each passage in coinfected NHBE cells were quantified by multiplex real-time reverse transcriptase PCR (RT-PCR) (see Fig. S1 in the supplemental material). Both HA and NA RNAs of TN/560 dominated early in the groups, with initial proportions of the pandemic virus that were equal to or higher than those of the seasonal virus ( Fig. S1A and B) . Evidence of reassortment between seasonal and pandemic strains was confirmed for the 90:10 NJ/15-TN/560 coinfection group starting from passage 1 (Fig. S1C) . Taken together, our findings showed that pandemic A/H1N1 dominated over its seasonal counterpart in the NHBE cell model used. However, the emergence of a reassortant between two A/H1N1 viruses was also observed, but only in the group with an initial dominance of the seasonal strain. The fact that such reassortant viruses acquired the HA gene from the seasonal A/H1N1 virus suggests that the pandemic HA gene segment may not yet be optimal for viral replication in humans.
To monitor the emergence of adaptive amino acid changes, the complete genomes of six clones isolated from each group were sequenced. HA K154Q (H1 numbering) and/or polymerase acid (PA) protein L295P mutations were observed in two groups with an initial 50% or 90% proportion of TN/560 (Table 1) . A polymerase basic 2 (PB2) protein D87N mutation was observed in all the clones recovered from the group with an initial predominance of NJ/15. The two A/H1N1 strains that represented two major genotypes isolated from coinfected NHBE cells were designated G1 (TN/560-like virus with PA L295P and HA K154Q) and G2 (reassortant NJ/15 HA in a TN/560 backbone with PB2 D87N) and were further analyzed (Table 1) .
Replication and pathogenicity of G1 and G2 viruses in cell culture and in ferrets. We first studied the growth of G1 and G2 viruses both in eggs and in MDCK cells (see Table S1 in the supplemental material). The yields of both viruses in cell culture were significantly higher (~1.5 logs) than those of their parental TN/ 560 and NJ/15 strains (P Ͻ 0.01). G1 and G2 formed larger plaques (diameter, 1.5 to 2.2 mm) than the parental counterparts (diameter, 0.6 to 1.1 mm) (Table S1 ). To assess the relative replication efficiencies of the G1 and G2 viruses, the multiple-cycle replication kinetics of these viruses in comparison with the levels for TN/560 and NJ/15 in NHBE cells were examined. The replication levels of G1 and G2 were significantly higher than those of both parents 24, 48, and 72 h after infection at 37°C (Ͼ0.9 to 1.8 logs; P Ͻ 0.05) ( Fig. 2A ). Higher titers of G1 and G2 than of TN/560 were also observed 48 and 72 hours after infection at 33°C (Ͼ0.6 to 1.3 logs; P Ͻ 0.05) (Fig. 2B) .
To determine whether the G1 and G2 variants acquired increased virulence in vivo, we further characterized the pathogenicity and transmissibility potentials of A/H1N1 viruses in ferrets. Four groups of two ferrets (Mustela putorius furo) each were inoculated with 10 6 PFU of TN/560, NJ/15, G1, or G2 (Table 2 ; see also Fig. S2 in the supplemental material). After 24 h, two naïve ferrets (contacts) were housed in the same cage with two inoculated ferrets (donors) to assess direct-contact transmission. All A/H1N1 viruses caused only mild clinical signs (relative inactivity index [RII], Ϸ0.1), without marked weight changes (~4 to 10%) (Table 2). The body temperature elevation was slightly higher in animals inoculated with G1 and G2 than in those inoculated with parental viruses (mean peak increases of 1.6°C and 0.4°C for donors and contacts, respectively). The donor ferrets inoculated with G1 had significantly higher nasal wash titers on day 1 postinoculation (p.i.) than the TN/560-infected animals had (P Ͻ 0.01). The duration of infectious-virus shedding was 2 days longer for animals inoculated with G1 or G2 viruses than for animals inoculated with either TN/560 or NJ/15 (Fig. S2A) . Although all four A/H1N1 strains transmitted efficiently, as shown by virus shedding as well as by seroconversion (Table 2 ), G1 and G2 contact ferrets exhibited significantly higher virus titers in the upper respiratory tract than the TN/560 group on all days studied (Ͼ1.5 to 3.8 logs; P Ͻ 0.01) (Fig. S2A) . Comparison of the protein concentrations and total cell counts in the nasal washes showed a statistically significant difference between G2 and all other viruses on day 2 p.i. (P Ͻ 0.01), suggesting an increased inflammation in the upper respiratory tract ( Fig. S2D and E).
To evaluate virus replication and tissue tropism of A/H1N1 viruses in ferrets, we determined virus titers in the lungs, nasal turbinate, trachea, spleen, liver, and small intestine of one inoculated ferret per group on day 3 p.i. (Fig. 2C ). While no evidence of infectious virus was found in the liver or spleen tissues of any animals tested, all four viruses were detected in the lungs and nasal turbinates. Consistent with the more-pronounced clinical signs of disease, G1 exhibited the widest tissue tropism and was detected at higher titers in three out of four lobes of the lungs (~6.8 log 10 50% tissue culture infective doses [TCID 50 ]/gram tissue) and small intestine (~3.4 log 10 TCID 50 /gram tissue) (Fig. 2C) . Histopathologic analysis revealed that the lungs of donor ferrets inoculated with G1 had significantly more necrotizing bronchiolitis and alveolitis than the lungs from animals infected with TN/560, NJ/15, or G2, which exhibited infection restricted either to the bronchioles or to the alveolar interstitium (Fig. 2D ). Taken together, our findings showed that two variants selected by coinfection of human cells acquired increased replicative fitness and virulence both in vitro and in vivo.
Effect of observed mutations on viral polymerase activity, receptor specificity, and antigenicity. A luciferase minigenome assay was used to study the role of ribonucleoprotein (RNP) complex mutations in the viral replication, comparing G1 and G2 to TN/560. The G1 RNP complex, carrying the PA L295P mutation, showed~20% more polymerase activity than TN/560 at 37°C (and comparable activities at 33°C and 39°C) (Fig. 3A) . The G2 RNP complex also had a significantly higher polymerase activity at 33°C (ϩ30%) but a slightly lower one at 39°C (Ϫ10%) than TN/ 560 RNP (P Ͻ 0.05) (Fig. 3A) . Interestingly, growth curves at 33°C showed that both G1 and G2 grew faster than TN/560 at later time points (Fig. 2B) , suggesting an advantage for the adapted viruses for replication in the upper respiratory tract. At least in the case of G2, it appears that the PB2 D87N mutation may play a role in viral replication and that this mutation functions by increasing polymerase activity. The discrepancy between comparative growth curve and polymerase assay data at 33°C for G1, however, clearly shows that polymerase activity is not the sole reason for increased viral production from human airway cells, at least at this temperature.
The receptor specificities of all four A/H1N1 viruses were also compared (Fig. 3B) (9) . The patterns of binding to fetuin were identical among all isolates (association constant [K ass ], Ϸ6.9 Ϯ 1.4; 1/M sialic acid) and negligible to the "aviantype" 3=-sialylglycopolymer (3=-SL). NJ/15 and G2 viruses showed significantly less binding to both "human-type" 6=-sialylglycopolymer (6=-SL) and 6=-sialyllactosamine (6=-SLN) receptors than did the pandemic TN/560 strain (~3-fold difference; P Ͻ 0.05) (Fig. 3B ). In contrast, the G1 variant (with the HA K154Q substitution) exhibited an affinity for the 6=-SLN sialic polymer similar to that observed for TN/560 but was unable to bind to 6=-SL, indicating that G1 discriminated both ␣2,6-linked receptors (Fig. 3B) . Given the preferential binding of human H1N1 viruses to a 6=-SLN receptor (10), our findings suggest that the HA K154Q mutation is a mammal-associated change that leads to better refinement of receptor-binding properties of currently circulating pandemic A/H1N1 viruses.
To test whether the acquired HA K154Q mutation changed the antigenic specificity of the pandemic TN/560 virus, we determined the antigenic properties of all A/H1N1 viruses in a hemagglutination inhibition (HI) test using postinfection ferret antisera and monoclonal antibodies (MAbs) raised against a selection of currently circulating seasonal, pandemic, and swine H1 isolates (see Table S2 in the supplemental material). TN/560 and G1 did not react with the ferret postinfection antisera or MAbs raised against contemporary human or swine H1 viruses, which was in good agreement with earlier findings (11) . G1 exhibited a slight change in reactivity with H5, E2, and H7 MAbs (Table S2 ), suggesting that the HA mutation at residue 154 may play a role in antigenicity.
DISCUSSION
In our study, coinfection of human airway cells with two A/H1N1 strains allowed us to study the possible interactions between viruses, which are difficult to assess on the basis of surveillance data (A and B) NHBE cultures were infected via the apical side with each virus at an MOI of 0.1 at either 37°C (A) or 33°C (B). The progeny viruses released from the apical surfaces of infected cultures were collected at the indicated time points and titrated in MDCK cells by performing a plaque assay. Representative results expressed as log 10 numbers of PFU/ml from three independent experiments are shown. *, P Ͻ 0.05;°, P Ͻ0.01 compared with the value for TN/560 virus (one-way ANOVA). (C) Four ferrets were intranasally inoculated with 10 6 PFU of each virus, and 3 days later, tissues were collected and virus titers were determined. Virus titers are expressed as log 10 TCID 50 /gram tissue for one ferret. (D) The images shown are hematoxylin-and-eosin-stained sections of lung tissue from donor ferrets inoculated with TN/560, G1, or G2 (H1N1) influenza viruses obtained on day 3 postinoculation. The TN/560 lung infection was primary restricted to the bronchioles and consisted of epithelial necrosis and regeneration associated with intraluminal sloughed epithelial cells and mononuclear inflammatory cells. The G1 infection involved the bronchioles and alveoli and consisted of bronchiolar epithelial necrosis and regeneration associated with alveolar pneumocytes hyperplasia and mononuclear inflammatory cell infiltrates. The pathologic changes in the G2-infected lungs were restricted to the alveolar interstitium only. The alveolar spaces were free of inflammatory cells, whereas the alveolar interstitial walls were hypercellular with mononuclear cells. Magnification, ϫ20.
alone. Although the NHBE model lacks a functional adaptive immune system, which would obviously play a role in virus adaptation, it is worth mentioning that our model correlated well with what has been seen in nature. Therefore, this work could be useful in identifying new possible A/H1N1 influenza virus evolution scenarios. Our findings suggest that generation of viable intrasubtype reassortment between currently circulating oseltamivir-resistant seasonal and pandemic viruses is possible but requires initial dominance of the seasonal A/H1N1 strain. Although we did not observe the emergence of a drug-resistant reassortant, the G2 variant was more fit than its parental strains for replication in ferrets. The lack of detection of such reassortants before now may be explained by a too-low ratio of seasonal to pandemic A/H1N1 strains.
We anticipate that the more favorable adaptation scenario for the A/H1N1 pandemic virus seems to tend toward an antigenic drift than a shift. Indeed, in two out of three coinfection groups studied, the pandemic genotype dominated. Our data showed that the acquisition of two nonsynonymous mutations in the HA (K154Q) and PA (L295P) genes resulted in rapid selection of the pandemic virus with improved replication and virulence. All pandemic A/H1N1 viruses except TN/560 possessed a proline at residue 295 in the PA protein, indicating a selective advantage for this mutation in the mammalian host, such as better replication in the upper respiratory tract, as confirmed by minigenome data. In contrast, the HA K154Q substitution identified in G1 was not present in any contemporary pandemic A/H1N1 influenza virus examined. Located next to the HA receptor-binding site, the K154Q mutation affected the protein structure such that binding to the 6=-SL receptor became impossible, probably because of an increase of the negative charge of the HA molecule. Thus, this HA mutation, resulting in a typical human virus-like preference due to strong recognition of only 6=-SLN sialosides, could contribute to the increased initial ability of the virus to infect and spread in the human airway and lung epithelium. In addition, it was determined previously that adaptation of the PB2 protein is also crucial for efficient transmission of A/H1N1 influenza virus (12) . In this study, a single mutation, PB2 D87N, was responsible for increased G2 RNP polymerase activity at the lower temperature (33°C) found in the mammalian airway and, therefore, probably contributed to better replication in the nose, significantly elevated inflammation, or more efficient transmission. It is noteworthy that alignment of full PB2 proteins showed the D87N mutation only in 0.06% of sequenced isolates. We believe that surveillance should involve careful examination of the adaptive changes identified here as possible markers for enhanced morbidity of the pandemic viruses. In conclusion, our study demonstrates that the emergence of a more virulent A/H1N1 pandemic strain is possible.
MATERIALS AND METHODS
Cell lines and viruses. MDCK and human embryonic kidney (293T) cells were obtained from the American Type Culture Collection. NHBE cells were obtained from Cambrex Bio Science. All cell cultures were maintained as previously described (13, 14) . For NHBE cell differentiation, culture medium was kept on both the basal and the apical sides of the cells for 10 to 14 days, until the cells formed a monolayer. The cells were then left at an air-liquid interface (with medium on the basal side only) for another 2 to 3 weeks so that they could differentiate into polarized cultures.
The seasonal NJ/15 and pandemic TN/560 (H1N1) influenza viruses were obtained from the World Health Organization collaborating laboratories. Stock viruses were prepared in MDCK cells at 37°C for 72 h, and aliquots were stored at -70°C until used.
Coinfection studies with NHBE cells. Duplicate differentiated NHBE cell cultures were washed extensively with sterile phosphate-buffered saline (PBS) and then were inoculated via the apical side with mixtures of seasonal NJ/15 and pandemic TN/560 virus pairs at different ratios (10:90, 50:50, and 90:10). NHBE cells were inoculated with mixtures of the two viruses at a multiplicity of infection (MOI) of 0.1 in 100 l of inoculum. After 1 h of incubation, the inoculum was removed, and the cells were then incubated at 37°C for 72 h. Viruses released into the apical compartment of NHBE cells were harvested by the apical addition and collection of 300 l of medium allowed to equilibrate for 30 min. Then, 100 l of the sample was used as an inoculum for the next passage.
Genotyping. To determine if reassortant viruses emerged in the apical medium samples of coinfected NHBE cultures, a genotyping analysis of plaque-purified viruses isolated from the harvested samples was performed after a total of 3 (n ϭ 25) or 10 (n ϭ 30) passages. After completion of genome analysis, two viruses representing G1 and G2 reassortant genotypes were subsequently cloned twice by plaque purification in MDCK cells, and the cloned viruses were passaged once in the MDCK cells for 72 h at 37°C to prepare a virus stock. One-step reverse transcriptase PCR (RT-PCR; Qiagen) was also used to determine the NJ/15-or TN/560-based origin of each gene in plaquepurified virus populations after a total of 3 (n ϭ 25) or 10 (n ϭ 30) passages in coinfected NHBE cells. Primers were designed to hybridize specifically to each NJ/15-or TN/560-derived gene segment at appropriate annealing temperatures (8) . Multiplex reactions using NJ/15-and TN/ 560-specific primers for each viral gene were performed to simultaneously detect both NJ/15-and TN/560-derived genes of different amplicon sizes. and TN/560, respectively). Real-time RT-PCR was performed using a Qiagen one-step RT-PCR kit, 600 nmol/liter of each primer, 500 nmol/liter of the TN/560-specific probe, 100 nmol/liter of the NJ/15-specific probe, and 2 mM MgCl 2 (Roche). Quantitative real-time RT-PCR was done using an ABI Fast real-time PCR system 7500 thermocycler and corresponding software (Stratagene), with the following cycling conditions: 50°C for 30 minutes and 95°C for 15 minutes, followed by 40 cycles of 94°C for 20 s, 58°C for 30 s, and 72°C for 40 s. RNA standards were quantified using a NanoDrop 1000 spectrophotometer (Thermo Scientific), and real-time RT-PCR efficiencies were similar for HA and NA RNA of NJ/15 and TN/560H1N1 viruses, ranging from 2.5 to 2.7.
Virus sequence analysis. Viral RNAs (vRNAs) were isolated from virus-containing cell culture fluid by using an RNeasy minikit (Qiagen). Samples were reverse transcribed and analyzed by PCR using universal primers, as described previously (15) . Sequencing was performed by the Hartwell Center for Bioinformatics and Biotechnology at St. Jude Children's Research Hospital and edited by using the Lasergene sequence analysis software package (DNASTAR).
Infectivity and replication kinetics of A/H1N1 influenza viruses. The infectivity of A/H1N1 viruses was determined by 50% tissue culture infective dose (TCID 50 ), PFU count, and 50% egg infectious dose (EID 50 ) as described previously (13, 16) .
To determine multistep growth curves for NHBE cells, triplicate cell cultures growing in 12-mm-diameter inserts were inoculated via the apical side with each virus at an MOI of 0.1 at 33°C or 37°C. After 1 h of incubation, the inoculum was removed. Viruses released into the apical compartment of NHBE cells were harvested at the indicated time points by the apical addition and collection of 300 l of medium allowed to equilibrate for 30 min at 33°C or 37°C. The virus titers were determined as log 10 numbers of PFU/ml in MDCK cells.
Assessment of virus pathogenicity and transmission in ferrets. Pathogenicity in 4-to 5-month-old male ferrets obtained from Marshall Farms (North Rose, NY) was tested. All ferrets were seronegative for influenza A H1N1, H3N2, and H5N1 and for influenza B viruses. Donor ferrets were initially housed separately from contact ferrets. The donor ferrets (two for each group) were inoculated intranasally under light isoflurane anesthesia with 10 6 PFU of NJ/15, TN/560, G1, or G2 virus in 1 ml of sterile PBS. For the direct-contact transmission experiment, 24 h after inoculation (day 1 postinoculation [p.i.] for the inoculated ferrets and day 0 postcontact [p.c.] for the contact ferrets), two naïve directcontact ferrets were housed in the cage with two donor ferrets. Clinical signs of infection, relative inactivity index (17) , weight, and temperature were recorded daily.
To monitor virus shedding, nasal washes were collected from ferrets on days 1, 2, 4, 6, 8, and 10 p.i. (or days 1, 3, 5, 7, and 9 p.c.). The virus titers were determined as log 10 TCID 50 /ml in MDCK cells. The limit of virus detection was 0.5 log 10 TCID 50 /ml. For calculation of the mean, samples with virus titers of Ͻ0.5 log 10 TCID 50 /ml were assigned a value of 0. Inflammatory cell counts and protein concentrations in nasal washes were also determined.
To determine inflammatory-cell counts, the nasal washes were centrifuged at 2,000 rpm for 10 min. The cell pellet was resuspended in PBS, and Polymerase activity of ribonucleoprotein complexes of TN/560, G1, and G2 (H1N1) viruses as determined by a dual-luciferase reporter assay in three independent experiments. 293T cells were transfected in triplicate with luciferase and Renilla reporter plasmids, together with plasmids expressing PB2, PB1, PA, and NP from either TN/560, G1, or G2 viruses. Cells were incubated at 33°C (orange bars), 37°C (red bars), or 39°C (purple bars) for 24 h, and cell lysates were analyzed to measure firefly luciferase and Renilla activities. The latter was used to normalize transfection efficiency. Values shown represent the activities of each ribonucleoprotein (RNP) complex relative to that of TN/560. *, P Ͻ 0.05;°, P Ͻ0.01 compared with the value for TN/560 virus (one-way ANOVA). (B) Receptor specificity of NJ/15, TN/560, G1, and G2 (H1N1) influenza viruses. Association constants (K ass ) of virus complexes with "human-type" sialylglycopolymers conjugated to 6=-SL and 6=-SLN are shown. Higher K ass values indicate stronger binding. Values are the means from four independent experiments. *, P Ͻ 0.05;°, P Ͻ0.01 compared with the value for TN/560 virus (one-way ANOVA).
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